Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038678 | SCV000062356 | benign | not specified | 2015-06-10 | criteria provided, single submitter | clinical testing | p.Leu37Leu in exon 2 of NEBL: This variant is not expected to have clinical sign ificance because it has been identified in 1.3% (88/6594) of Finnish chromosomes , including 1 homozygote by the Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org; dbSNP rs140734883). |
Gene |
RCV000038678 | SCV000236075 | benign | not specified | 2014-09-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000226777 | SCV000289515 | benign | Primary dilated cardiomyopathy | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000038678 | SCV002734634 | likely benign | not specified | 2022-05-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001701580 | SCV004126538 | benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | NEBL: BS1, BS2 |
Prevention |
RCV003914949 | SCV004735783 | benign | NEBL-related condition | 2019-05-03 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001701580 | SCV001928885 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701580 | SCV001975406 | likely benign | not provided | no assertion criteria provided | clinical testing |